Takeda Renews Deal with Proteome Sciences

Takeda will use the PS Biomarker Services for the development of mass spectrometry-based assays for disease-related proteins.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories